Novel role of pleckstrin homology domain of the Bcr-Abl protein: Analysis of protein–protein and protein–lipid interactions

Experimental Cell Research

Volumn 316, Issue 4, 2010, Pages 530-542

  Miroshnychenko, Daria ^a   Dubrovska, Anna ^b   Maliuta, Stanislav ^a   Telegeev, Gennady ^a   Aspenström, Pontus ^c  

^a INSTITUTE OF MOLECULAR BIOLOGY AND GENETICS   (Ukraine)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Bcr Abl; Leukemia; Pleckstrin homology domain

Indexed keywords

BACTERIAL PROTEIN; BCR ABL PROTEIN; HYBRID PROTEIN; PHOSPHATIDYLINOSITIDE; PLC EPSILON PROTEIN; PLECKSTRIN; POLYHISTIDINE TAG; PROTEIN; SHORT HAIRPIN RNA; SMC1 PROTEIN; SULFUR 35; TUBULIN; UNCLASSIFIED DRUG; WORTMANNIN; ZIZIMIN1 PROTEIN; BIOLOGICAL MARKER; PHIP PROTEIN, HUMAN; PHOSPHATIDYLINOSITOL; SIGNAL PEPTIDE;

APOPTOSIS; ARTICLE; CELL ADHESION; CELL CYCLE; CELL LYSATE; CELL MOTILITY; CELL PROLIFERATION; CELL TRANSFORMATION; CELLULAR DISTRIBUTION; CHRONIC MYELOID LEUKEMIA; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOSKELETON; ENDOSOME; FLUORESCENCE MICROSCOPY; GOLGI MEMBRANE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; LEUKEMOGENESIS; MYELOID LEUKEMIA CELL LINE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN LIPID INTERACTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEOMICS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; ANIMAL; CELL LINE; CELL STRAIN COS1; CELL STRAIN K 562; CERCOPITHECUS; GENETICS; METABOLISM; ONCOGENE; PHYSIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; BIOLOGICAL MARKERS; CELL LINE; CERCOPITHECUS AETHIOPS; COS CELLS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GENES, ABL; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; K562 CELLS; MICROSCOPY, FLUORESCENCE; PHOSPHATIDYLINOSITOLS; PROTEIN BINDING; PROTEOMICS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 77449124904     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2009.11.014     Document Type: Article

References (33)

1. [1] Daley, G.Q., Van Etten, R.A., Baltimore, D., Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome. Science 247 (1990), 824–830.
2. [2] Clark, S.S., McLaughlin, J., Timmons, M., Pendergast, A.M., Ben Neriah, Y., Dow, L.W., Crist, W., Rovera, G., Smith, S.D., Witte, O.N., Expression of a distinctive BCR-ABL oncogene in Ph1-positive acute lymphocytic leukemia (ALL). Science 239 (1988), 775–777.
3. [3] Pane, F., Frigeri, F., Sindona, M., Luciano, L., Ferrara, F., Cimino, R., Meloni, G., Saglio, G., Salvatore, F., Rotoli, B., Neutrophilic-chronic myeloid leukemia: a distinct disease with a specific molecular marker (BCR/ABL with C3/A2 junction). Blood 88 (1996), 2410–2414.
4. [4] Chuang, T.H., Xu, X., Kaartinen, V., Heisterkamp, N., Groffen, J., Bokoch, G.M., Abr and Bcr are multifunctional regulators of the Rho GTP-binding protein family. Proc. Natl. Acad. Sci. U. S. A. 92 (1995), 10282–10286.
5. [5] Lemmon, M.A., Pleckstrin homology (PH) domains and phosphoinositides. Biochem. Soc. Symp., 2007, 81–93.
6. [6] Kavran, J.M., Klein, D.E., Lee, A., Falasca, M., Isakoff, S.J., Skolnik, E.Y., Lemmon, M.A., Specificity and promiscuity in phosphoinositide binding by pleckstrin homology domains. J. Biol. Chem. 273 (1998), 30497–30508.
7. [7] Rameh, L.E., Arvidsson, A., Carraway, K.L., III, A.D., Couvillon, G., Rathbun, A., Crompton, B., VanRenterghem, M.P., Czech, K.S., Ravichandran, S.J., Burakoff, D.S., Wang, C.S., Chen, L.C., Cantley, A, comparative analysis of the phosphoinositide binding specificity of pleckstrin homology domains. J. Biol. Chem. 272 (1997), 22059–22066.
8. [8] Chen, C., Okayama, H., High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7 (1987), 2745–2752.
9. [9] Hassel, S., Eichner, A., Yakymovych, M., Hellman, U., Knaus, P., Souchelnytskyi, S., Proteins associated with type II bone morphogenetic protein receptor (BMPR-II) and identified by two-dimensional gel electrophoresis and mass spectrometry. Proteomics 4 (2004), 1346–1358.
10. [10] Kanamoto, T., Hellman, U., Heldin, C.H., Souchelnytskyi, S., Functional proteomics of transforming growth factor-beta1-stimulated Mv1Lu epithelial cells: Rad51 as a target of TGFbeta1-dependent regulation of DNA repair. EMBO J. 21 (2002), 1219–1230.
11. [11] Gobom, J., Nordhoff, E., Mirgorodskaya, E., Ekman, R., Roepstorff, P., Sample purification and preparation technique based on nano-scale reversed-phase columns for the sensitive analysis of complex peptide mixtures by matrix-assisted laser desorption/ionization mass spectrometry. J. Mass Spectrom. 34 (1999), 105–116.
12. [12] Lemmon, M.A., Ferguson, K.M., Molecular determinants in pleckstrin homology domains that allow specific recognition of phosphoinositides. Biochem. Soc. Trans. 29 (2001), 377–384.
13. [13] Lemmon, M.A., Ferguson, K.M., Signal-dependent membrane targeting by pleckstrin homology (PH) domains. Biochem. J. 350 (2000), 1–18.
14. [14] De Matteis, M.A., D'Angelo, G., The role of the phosphoinositides at the Golgi complex. Biochem. Soc. Symp., 2007, 107–116.
15. [15] De Matteis, M.A., Di Campli, A., D'Angelo, G., Lipid-transfer proteins in membrane trafficking at the Golgi complex. Biochim. Biophys. Acta 1771 (2007), 761–768.
16. [16] Roth, M.G., Phosphoinositides in constitutive membrane traffic. Physiol Rev. 84 (2004), 699–730.
17. [17] Grant, B.D., Sato, M., Intracellular trafficking. WormBook, 2006, 1–9.
18. [18] Downing, G.J., Kim, S., Nakanishi, S., Catt, K.J., Balla, T., Characterization of a soluble adrenal phosphatidylinositol 4-kinase reveals wortmannin sensitivity of type III phosphatidylinositol kinases. Biochemistry 35 (1996), 3587–3594.
19. [19] Gupta, A., Prasad, K., Hematological and molecular response evaluation of CML patients on imatinib. J. Assoc. Phys. India 55 (2007), 109–113.
20. [20] Jabbour, E., Kantarjian, H.M., Jones, D., Reddy, N., O'Brien, S., Garcia-Manero, G., Burger, J., Cortes, J., Characteristics and outcome of patients with F317L BCR-ABL kinase domain mutation after therapy with tyrosine kinase inhibitors. Blood 112 (2008), 4839–4842.
21. [21] Kantarjian, H., Cortes, J., BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia: using guidelines to make rational treatment choices. J. Natl. Compr. Cancer Netw., 2008, S37–S42.
22. [22] Melo, J.V., The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype. Blood 88 (1996), 2375–2384.
23. [23] Alberti, S., A phosphoinositide-binding sequence is shared by PH domain target molecules–a model for the binding of PH domains to proteins. Proteins 31 (1998), 1–9.
24. [24] Meller, N., Irani-Tehrani, M., Ratnikov, B.I., Paschal, B.M., Schwartz, M.A., The novel Cdc42 guanine nucleotide exchange factor, zizimin1, dimerizes via the Cdc42-binding CZH2 domain. J. Biol. Chem. 279 (2004), 37470–37476.
25. [25] Mouneimne, G., Soon, L., DesMarais, V., Sidani, M., Song, X., Yip, S.C., Ghosh, M., Eddy, R., Backer, J.M., Condeelis, J., Phospholipase C and cofilin are required for carcinoma cell directionality in response to EGF stimulation. J. Cell Biol. 166 (2004), 697–708.
26. [26] Yazdi, P.T., Wang, Y., Zhao, S., Patel, N., Lee, E.Y., Qin, J., SMC1 is a downstream effector in the ATM/NBS1 branch of the human S-phase checkpoint. Genes Dev. 16 (2002), 571–582.
27. [27] Schreiner, P., Chen, X., Husnjak, K., Randles, L., Zhang, N., Elsasser, S., Finley, D., Dikic, I., Walters, K.J., Groll, M., Ubiquitin docking at the proteasome through a novel pleckstrin-homology domain interaction. Nature 453 (2008), 548–552.
28. [28] Hurley, J.H., Lee, S., Prag, G., Ubiquitin-binding domains. Biochem. J. 399 (2006), 361–372.
29. [29] Cho, W., Stahelin, R.V., Membrane-protein interactions in cell signaling and membrane trafficking. Annu. Rev. Biophys. Biomol. Struct. 34 (2005), 119–151.
30. [30] Czech, M.P., Dynamics of phosphoinositides in membrane retrieval and insertion. Annu. Rev. Physiol. 65 (2003), 791–815.
31. [31] Rusten, T.E., Stenmark, H., Analyzing phosphoinositides and their interacting proteins. Nat. Methods 3 (2006), 251–258.
32. [32] Downes, C.P., Gray, A., Lucocq, J.M., Probing phosphoinositide functions in signaling and membrane trafficking. Trends Cell Biol. 15 (2005), 259–268.
33. [33] Olabisi, O.O., Mahon, G.M., Kostenko, E.V., Liu, Z., Ozer, H.L., Whitehead, I.P., Bcr interacts with components of the endosomal sorting complex required for transport-I and is required for epidermal growth factor receptor turnover. Cancer Res. 66 (2006), 6250–6257.